Global On-body Injectors Supply, Demand and Key Producers, 2023-2029

Global On-body Injectors Supply, Demand and Key Producers, 2023-2029

The global On-body Injectors market size is expected to reach $ 378.9 million by 2029, rising at a market growth of 14.4% CAGR during the forecast period (2023-2029).

In the global market, On-body Injectors is dominated by core players such as AWest Pharmaceutical Services, Insulet, Gerresheimer, ect. The top three players within this industry account for about 80% of the market share. North America, Europe, and Asia-Pacific are the major manufacturing regions for this product, and they all hold about 15% of the global market share. The product can be categorised on the basis of product type into electronic syringes and mechanical syringes. The product is widely used in the treatment of oncology immunology, cardiovascular diseases, neurological disorders, and other diseases.

On-body injectors, also known as on-body delivery systems (OBDS), are medical devices designed to deliver a controlled dose of medication or therapeutic substances subcutaneously (under the skin) over a specified period. These devices are typically worn on the body and are used to administer various treatments, including medications, hormones, and biologics. On-body injectors offer several advantages, including increased patient convenience, improved medication adherence, and the ability to deliver complex therapies.

The scope of this report is non-insulin On-body injectors.

This report studies the global On-body Injectors production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for On-body Injectors, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of On-body Injectors that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global On-body Injectors total production and demand, 2018-2029, (K Units)

Global On-body Injectors total production value, 2018-2029, (USD Million)

Global On-body Injectors production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global On-body Injectors consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: On-body Injectors domestic production, consumption, key domestic manufacturers and share

Global On-body Injectors production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global On-body Injectors production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global On-body Injectors production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units).

This reports profiles key players in the global On-body Injectors market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include West Pharmaceutical Services, Insulet, Gerresheimer, United Therapeutics, CC Bio, BD, Ypsomed, Enable Injections and Nemera, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World On-body Injectors market.

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global On-body Injectors Market, By Region:
United States
China
Europe
Japan
South Korea
ASEAN
India
Rest of World

Global On-body Injectors Market, Segmentation by Type
Electronic Injectors
Mechanical Injectors

Global On-body Injectors Market, Segmentation by Application
Immuno-oncology
Cardiovascular Diseases
Neurological Diseases
Others

Companies Profiled:
West Pharmaceutical Services
Insulet
Gerresheimer
United Therapeutics
CC Bio
BD
Ypsomed
Enable Injections
Nemera
Stevanato Group
Sonceboz
Lohmann Therapie-Systeme
Elcam Drug Delivery Devices (E3D)

Key Questions Answered

1. How big is the global On-body Injectors market?

2. What is the demand of the global On-body Injectors market?

3. What is the year over year growth of the global On-body Injectors market?

4. What is the production and production value of the global On-body Injectors market?

5. Who are the key producers in the global On-body Injectors market?